These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6392599)
41. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens. Dong J; Ruan J; Xu N; Yang Y; Ai X FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906 [TBL] [Abstract][Full Text] [Related]
42. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076 [TBL] [Abstract][Full Text] [Related]
43. Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system. Sifuentes-Osornio J; Ruiz-Palacios GM; Gröschel DH J Clin Microbiol; 1986 Feb; 23(2):230-4. PubMed ID: 3517048 [TBL] [Abstract][Full Text] [Related]
44. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution]. Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H Jpn J Antibiot; 1986 Nov; 39(11):2959-3006. PubMed ID: 3102808 [TBL] [Abstract][Full Text] [Related]
45. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital]. Ronco E; Vacheron F; Orabona A Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708 [TBL] [Abstract][Full Text] [Related]
46. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics]. Filloy L; Serrano D; Borjas E Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092 [TBL] [Abstract][Full Text] [Related]
47. Comparative evaluation of five aminoglycosides for treatment. Rosin H; Naumann P; Reintjens E; Köhler M Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656 [TBL] [Abstract][Full Text] [Related]
48. [Studies on the combination action of sisomicin, gentamicin and cefmenoxime, ceftizoxime, cefoperazone, cefotetan against Serratia marcescens and Pseudomonas aeruginosa]. Kubo M; Kato Y; Inamori Y Jpn J Antibiot; 1985 Dec; 38(12):3487-96. PubMed ID: 3938819 [TBL] [Abstract][Full Text] [Related]
49. Spheroplast induction in clinical isolates of Serratia marcescens in the presence of Ca2+ or Mg2+. Tada Y; Yamaguchi J J Clin Microbiol; 1987 Nov; 25(11):2154-8. PubMed ID: 3320083 [TBL] [Abstract][Full Text] [Related]
50. [Sero-types and drug sensitivity of Serratia marcescens isolated from pathological specimens, with special reference to hospital infections. II. (author's transl)]. Yama H; Yamada K; Tsujimoto T Jpn J Antibiot; 1979 Jun; 32(6):661-7. PubMed ID: 381707 [No Abstract] [Full Text] [Related]
51. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens. Ullmann U; Lindemann B Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966 [TBL] [Abstract][Full Text] [Related]
52. [Antimicrobial activities of gentamicin against fresh clinical isolates]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K; Fukumoto T Jpn J Antibiot; 1990 Oct; 43(10):1674-84. PubMed ID: 2128340 [TBL] [Abstract][Full Text] [Related]
53. [Genes of resistance to aminoglycoside antibiotics in clinical strains of Serratia marcescens and the enzyme encoded by them]. Kolganov AN; Vakulenko SB Antibiot Khimioter; 1992 Nov; 37(11):10-4. PubMed ID: 1300924 [TBL] [Abstract][Full Text] [Related]
54. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353 [TBL] [Abstract][Full Text] [Related]
55. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)]. Jotzoff M Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734 [TBL] [Abstract][Full Text] [Related]
56. In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens. Traub WH Chemotherapy; 1980; 26(2):103-10. PubMed ID: 6988181 [TBL] [Abstract][Full Text] [Related]
57. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1983). III. Secular changes in susceptibility]. Kosakai N; Igari J; Kumamoto Y; Sakai S; Shigeta S; Shiraiwa Y; Abe K; Tazaki H; Iri H; Uchida H Jpn J Antibiot; 1985 Aug; 38(8):2243-312. PubMed ID: 3935824 [TBL] [Abstract][Full Text] [Related]
59. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim. Traub WH; Fukushima PI Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575 [TBL] [Abstract][Full Text] [Related]
60. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes. Aucken HM; Pitt TL J Med Microbiol; 1998 Dec; 47(12):1105-13. PubMed ID: 9856647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]